Transformed eukaryotic cells

Details Transformed eukaryotic cells Transformed eukaryotic cells

1997-07-16

2000-12-05

LeGuyader, John L.

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

435 6, 435 691, 4353201, 435410, 435455, 435468, 536 231, 536 241, C12N 1585, C12N 1582, C07H 2104

Patent

active

061565687

ABSTRACT:
Novel means have been discovered for increasing the resistance of an animal host (including humans) to diseases caused by intracellular bacteria, protozoa, and viruses. The infection treated may, for example, be equine infectious anemia, or infection by the human immunodeficiency virus. Novel means have also been found for treating tumors. Augmentation of the host's defenses against infectious diseases or tumors is achieved by "arming" the host's cells with an exogenous gene encoding a natural or synthetic lytic peptide. For example, the transfection of hematopoietic stem cells and embryonic cells will produce animals with enhanced disease resistance; and transfection of TIL (tumor infiltrating lymphocytes) cells or other cells can be used in the treatment of tumors. Genes coding for a cecropin or other native or synthetic lytic peptide can be transferred and stably expressed in mammalian, bony fish, other vertebrate, and other animal cells. The transformed cells have the ability to produce and secrete a broad spectrum chemotherapeutic agent that has a systemic effect on certain pathogens, particularly pathogens that might otherwise evade or overcome host defenses. Novel means have also been discovered for transforming a eukaryotic cell with a gene under the control of an exogenous promoter that is responsive to an inducer of an acute-phase peptide or protein. For example, a moth promoter for the cecropin B gene has been found to function appropriately in a mammalian cell.

REFERENCES:
patent: 5556782 (1996-09-01), Cooper et al.
patent: 5597945 (1997-01-01), Jaynes et al.
patent: 5597946 (1997-01-01), Jaynes et al.
patent: 5719055 (1998-02-01), Cooper
patent: 5861478 (1999-01-01), Jaynes
patent: 5962410 (1999-10-01), Jaynes et al.
Palmiter et al. Science vol. 222, p. 809-814, Nov. 1983.
Pursel et al., J. Reprod. Fert., Suppl. 40, p. 235-245, 1990.
Kappel et al., Current Opinion in Biotechnology, 3: 548-553, 1992.
Bradley et al., Biotechnology vol. 40, p. 534-539, May. 1992.
Andersons et al., Biochem. J. 280: 219-224, 1991.
Gudmundsson et al., The Journal of Biological Chemistry, vol. 266(18), p. 11510-11517, 1991.
Jaynes et al., Plant Science, 89: 43-53, Apr. 1993.
Mastrangelo et al., Seminars in Oncology, vol. 23(1), p. 4-21, Feb. 1996.
Gwadz et al., Infection and Immunity, vol. 57(9), p. 2628-2633, Sep. 1989.
Xanthopoulas et al., "The structure of the gene of cecropin B, an antibacterial immune protein from Hyalophora cecropia," Eur. J. Biochem., vol. 172, pp. 371-376 (1988).
Kaling et al., "Liver-Specific Gene Expression: A-Activator-Binding Site, a Promoter Module Present in Vitellogen and Acute-Phase Genes," Mol. Cell. Biol., vol. 11, pp. 93-101 (1991).
Boman et al., "Cell-free immunity in Cecropia," Eur. J. Biochem., vol. 201, pp. 23-31 (1991).
Beck et al., "Invertebrate Cytokines III: Invertebrate Interleukin-1-Like Molecules Stimulate Phagocytosis by Tunicate and Enchinoderm Cells," Cellular Immunology, vol. 146, pp. 284-299 (1993).
Caput et al., "Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators," Proc. Natl. Acad. Sci. USA, vol. 83, pp. 1670-1674 (1986).
Morvan et al., "In vitro activity of the antimicrobial peptide magainin 1 against Bonamia ostreae, the intrahemocytic parasite of the flat oyster Ostrea edulis," Mol. Mar. Biol., vol. 3, pp. 327-333 (1994).
Cooper et al., "Transgenic Catfish Expressing a Lytic Peptide Gene," in Research and Review, A Compilation of Abstracts of Research on Channel Catfish, Catfish Farmers of America (1995).
U.S. application No. 08/5282, Cooper et al., filed Jun. 30, 1993.
A. Miller, "Human Gene Therapy Comes of Age," Nature, vol. 357, pp. 455-460 (1992).
P. Kylsten et al., "The cecropin locus in Drosophila; a Compact Gene Cluster Involved in the Response to Infection," E.M.B.O. J., vol. 9, pp. 217-224 (1990).
J. Reichhart et al., "Insect Immunity: Developmental and Inducible Activity of the Drosophila Diptericin Promoter," E.M.B.O. J. vol. 11, pp. 1469-1477 (1992).
Y. Tryselius et al., "CecC, a Cecropin Gene Expressed During Metamorphosis in Drosophila Pupae," Eur. J. Biochem., vol. 204, pp. 395-399 (1992).
G. Ciliberto et al., "Inducible and Tissue-Specific Expression of Human C-reactive Protein in Transgenic Mice," E.M.B.O. J., vol. 6, pp. 4017-4022 (1987).
Pelham et al., "DNA Sequences Required for Transcriptional Regulation of the Drosophila hsp70 Heat-Shock Gene in Monkey Cells and Xenopus Oocytes," in (Schlessinger et al., eds.) Heat Shock From Bacteria to Man, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 43-48 (1982).

Affiliated with

Also associated with

Rating

Transformed eukaryotic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transformed eukaryotic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transformed eukaryotic cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-960682